Current role
Stuart Poulton
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Karyopharm Therapeutics Inc. (KPTI)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Karyopharm Therapeutics Inc. (KPTI) | Executive Vice President, Chief Development Officer | $500,135 | $1,399,580 |
| 2024 | Karyopharm Therapeutics Inc. (KPTI) | Executive Vice President, Chief Development Officer | — | — |
| 2023 | Karyopharm Therapeutics Inc. (KPTI) | — | $477,000 | $1,109,115 |
| 2022 | Karyopharm Therapeutics Inc. (KPTI) | — | $373,910 | $1,779,848 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.